Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ)

4.5600
+0.2800
+(6.54%)
At close: 3:04:30 PM GMT+8
Loading Chart for 002513.SZ
  • Previous Close 4.2800
  • Open 4.4300
  • Bid 4.5700 x --
  • Ask 4.5800 x --
  • Day's Range 4.3300 - 4.6600
  • 52 Week Range 3.0200 - 9.1700
  • Volume 25,475,600
  • Avg. Volume 10,786,962
  • Market Cap (intraday) 1.711B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 13, 2017
  • 1y Target Est --

Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers carbendazim, thiophanate-methyl, cycloazinone, carbosulfan butyl, sulfuric acid, and surfactant. The company was founded in 1976 and is based in Xinyi, China.

www.jslanfeng.com

1,573

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002513.SZ

View More

Performance Overview: 002513.SZ

Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002513.SZ
1.79%
SSE Composite Index (000001.SS)
1.06%

1-Year Return

002513.SZ
6.79%
SSE Composite Index (000001.SS)
5.58%

3-Year Return

002513.SZ
5.56%
SSE Composite Index (000001.SS)
10.48%

5-Year Return

002513.SZ
15.15%
SSE Composite Index (000001.SS)
15.22%

Compare To: 002513.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002513.SZ

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    1.61B

  • Enterprise Value

    1.67B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.81

  • Price/Book (mrq)

    128.16

  • Enterprise Value/Revenue

    0.85

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.85%

  • Return on Assets (ttm)

    -8.94%

  • Return on Equity (ttm)

    -392.40%

  • Revenue (ttm)

    2.41B

  • Net Income Avi to Common (ttm)

    -381.32M

  • Diluted EPS (ttm)

    -0.6600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    325.79M

  • Total Debt/Equity (mrq)

    6,906.59%

  • Levered Free Cash Flow (ttm)

    -104.68M

Research Analysis: 002513.SZ

View More

Company Insights: 002513.SZ

Research Reports: 002513.SZ

View More

People Also Watch